Skip to content
Home

Category: Prostate Cancer

Rapid raise in Prostate Specific Antigen levels are poor predictors of Prostate Cancer

February 28, 2011 by srrpenna

A sudden spike in blood levels of prostate specific antigen, or PSA, is not an accurate way to predict prostate cancer, and testing for such changes can lead to overtreatment, U.S. researchers said on Thursday.

Study finds acceptable levels of anxiety among men living with early, untreated prostate cancer

July 27, 2009 by srrpenna

Men with early stages of prostate cancer who delay radical treatment in favor of an approach of "expectant management" do not have high levels of anxiety and distress. That is the conclusion of a new study published in the September 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society. The study's results suggest that living with untreated cancer is not upsetting for many patients with early prostate cancer.

Cancer vaccines show promise in Phase 3 trials

July 16, 2009 by srrpenna

Three cancer vaccines -- for prostate cancer, melanoma and lymphoma -- have achieved positive results in so-called Phase 3 clinical trials.

At the annual meeting of the American Society of Clinical Oncology held May 29 to June 2, researchers reported that a vaccine against follicular lymphoma, called BiovaxID, delayed remission after chemotherapy by more than one year, on average.

At the same meeting, other researchers said that a melanoma vaccine caused tumors to shrink in twice as many patients as those receiving a standard FDA-approved therapy.

AdaptiveThemes